Feng Chi Biotech Corp. (6744.TWO)
TWD 19.7
(0.0%)
TWD 19.7
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 301.03 Million TWD | -2.38% |
| 2022 | 308.36 Million TWD | 7.56% |
| 2021 | 286.69 Million TWD | 0.95% |
| 2020 | 283.99 Million TWD | 6.23% |
| 2019 | 267.32 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 299.85 Million TWD | 0.0% |
| 2024 Q1 | 299.85 Million TWD | -0.39% |
| 2023 Q1 | 311.31 Million TWD | 0.96% |
| 2023 FY | 301.03 Million TWD | -2.38% |
| 2023 Q4 | 301.03 Million TWD | 0.0% |
| 2023 Q3 | 301.03 Million TWD | -3.3% |
| 2023 Q2 | 311.31 Million TWD | 0.0% |
| 2022 Q4 | 308.36 Million TWD | 0.0% |
| 2022 FY | 308.36 Million TWD | 7.56% |
| 2022 Q3 | 308.36 Million TWD | 0.0% |
| 2021 FY | 286.69 Million TWD | 0.95% |
| 2020 FY | 283.99 Million TWD | 6.23% |
| 2019 FY | - TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -13.744% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 73.45% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -103.491% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 68.035% |
| NaviFUS Corp. | 490.53 Million TWD | 38.632% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 65.912% |
| TaiRx, Inc. | 833.74 Million TWD | 63.894% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 77.92% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 91.63% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -309.244% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 81.825% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -135.095% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 89.623% |
| AP Biosciences Inc | 890.75 Million TWD | 66.205% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 86.057% |
| RBC Bioscience Corporation | 753.79 Million TWD | 60.064% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 90.309% |
| EirGenix Inc. | 11.16 Billion TWD | 97.303% |
| Enimmune corporation | 604.82 Million TWD | 50.228% |
| Lukas Biomedical Inc. | 441.19 Million TWD | 31.768% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 83.075% |
| 3D Global Biotech Inc. | 324.14 Million TWD | 7.131% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 92.269% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 92.016% |
| TCI GENE Inc. | 1.16 Billion TWD | 74.181% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | 20.438% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 98.041% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | 26.624% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | 45.142% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | 24.145% |
| Neith Corporation | 192.15 Million TWD | -56.663% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 82.42% |
| VBI | 452.1 Million TWD | 33.415% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 85.499% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 74.405% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 74.043% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 90.245% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | 43.11% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -2.19% |
| Visgeneer Inc. | 397.17 Million TWD | 24.207% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 74.08% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | 47.477% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 75.44% |
| Sagittarius Life Science Corp | 664.72 Million TWD | 54.713% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 71.343% |
| GlycoNex Incorporation | 1.55 Billion TWD | 80.614% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 96.47% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 77.428% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 92.386% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 88.896% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 59.786% |
| BiOptic Inc. | 613.77 Million TWD | 50.954% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 75.523% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 77.919% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 56.9% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 94.628% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 92.125% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | 53.317% |
| Level Biotechnology Inc. | 822.67 Million TWD | 63.408% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 95.059% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 71.654% |
| Acepodia, Inc. | 6.81 Billion TWD | 95.585% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 92.133% |